This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Colostrum
Our depth — beyond the mirror
Deeper analysis, verdict reasoning, and per-archetype recommendations from our research team.
▸ Editor's verdict OPTIONAL-ADD MEDIUM
Replicated B-tier evidence in the most relevant niche for this user — URTI reduction (Davison 2007 PMID 17446836; Brinkworth 2003 PMID 12923655; Crooks 2006 PMID 16676703) and attenuation of exercise- + NSAID-induced gut permeability (Marchbank 2011 PMID 21148400; Halasa 2017 PMID 28397754; March 2017 PMID 28316573) at 20g/day. Effect sizes modest but honest. Combat-sport context with heavy training load + frequent gut/respiratory exposures fits the Davison cohort well. Oral IGF-1 absorption is mostly degraded — systemic IGF-1 / "anabolic" claims are oversold (Davison 2021 review PMID 34073917 confirmed null for sustained IGF-1 elevation across dose ranges). Verdict is OPTIONAL-ADD not STRONG because (a) glutamine + BPC-157 already cover most of his gut barrier slot; (b) cost and protein-load are non-trivial at 20-40g/day; (c) a true milk allergy or significant lactose intolerance can flip benefit to harm. Would upgrade to STRONG-CANDIDATE if he develops a recurrent URTI pattern during fight camps, documents elevated zonulin or post-training endotoxin spillover, or runs a heavy NSAID block. Would downgrade if he tolerates V4 baseline + BPC-157 + glutamine without URTI/gut symptoms.
▸ Decision matrix by user profile Per-archetype
| Archetype | Verdict | Rationale |
|---|---|---|
★20-30, brain-priority + MMA + business owner (Dylan archetype) | OPTIONAL-ADD | / MEDIUM baseline, STRONG-CANDIDATE during fight camps. Cognitive evidence nil. Relevant value: URTI reduction during pre-comp camps + travel, gut-permeability cover, immune buffer during training + work-stress overlap. Davison cohort transfers reasonably to MMA pre-comp (high volume + sleep debt + travel + weight-cut + locker-room exposure). Layer on V4/V5 only during heavy training blocks. |
30-50, executive maintenance | SKIP-FOR-NOW | or OPTIONAL-ADD. No cognitive/cardiometabolic benefit. If gut symptoms or frequent URTI present → OPTIONAL-ADD. MEDIUM confidence. |
50+, mild cognitive decline / longevity | SKIP-FOR-NOW | No longevity evidence; theoretical IGF-1/dairy-cancer concern is largely overblown for oral BC but precautionary frame still applies in active cancer surveillance. LOW confidence. |
Athletic male 18-35, high training load | STRONG-CANDIDATE | during pre-comp peaking; OPTIONAL-ADD baseline. Davison cohort fits this profile. 20 g/day during 4-8 wk heavy blocks; cycle off during deloads. |
High athletic load, drug-tested (WADA / USADA / collegiate / amateur) | OPTIONAL-ADD | WADA-permitted (not prohibited). Avoid "hyper-IGF-1"-marketed products. Stick to standard OTC + NSF Certified for Sport. |
Frequent URTI / repeated colds during fight camps | STRONG-CANDIDATE | Strongest evidence base; ~30-45% URTI day reduction (Jones 2016 meta-analysis). |
Heavy NSAID use (chronic ibuprofen/naproxen for training pain) | STRONG-CANDIDATE | Marchbank/Davison NSAID-induced gut injury attenuation. Pair 20 g/day with NSAID block. |
Documented leaky gut / elevated zonulin / IBS / IBD | STRONG-CANDIDATE | Add to glutamine / glycine / probiotic / BPC-157 protocol. Halasa 2017 confirms direct zonulin reduction. |
Suspected (unmeasured) leaky gut | POSSIBLE | / under-researched. Mechanism plausible but evidence base weak for unconfirmed symptom clusters; trial 20 g/day × 8 wk and assess. |
Pregnancy / breastfeeding | LIKELY | SAFE (whole-food dairy, no documented harm) but no RCT data. Defer to OB if concerned. |
Cancer family history (hormone-sensitive cancers) | CAUTION | Oral BC does not meaningfully elevate systemic IGF-1 (Davison 2021), so concern is overblown — but defer to oncologist in active surveillance. |
True milk allergy (IgE-mediated) | HARD-BLOCK | Cross-reactive with casein, beta-lactoglobulin, alpha-lactalbumin. Risk of anaphylaxis. |
Lactose intolerance (mild-moderate) | POSSIBLE | Most processed BC has <2% lactose, but not zero. Trial 5-10 g first; if GI distress persists, stop. Goat-derived (Mt. Capra) tolerated better by some. |
Strict vegan / dairy-avoidance ethics | HARD-BLOCK | by user preference. No vegan substitute matches the IgG/lactoferrin matrix. |
Combat-sport pre-competition (Dylan-specific) | STRONG-CANDIDATE | during 6-8 wk pre-comp camp. Layer 20 g/day AM on V4/V5 baseline. Discontinue 1 wk pre-fight to avoid GI surprise. |
- ★20-30, brain-priority + MMA + business owner (Dylan archetype)OPTIONAL-ADD
/ MEDIUM baseline, STRONG-CANDIDATE during fight camps. Cognitive evidence nil. Relevant value: URTI reduction during pre-comp camps + travel, gut-permeability cover, immune buffer during training + work-stress overlap. Davison cohort transfers reasonably to MMA pre-comp (high volume + sleep debt + travel + weight-cut + locker-room exposure). Layer on V4/V5 only during heavy training blocks.
- 30-50, executive maintenanceSKIP-FOR-NOW
or OPTIONAL-ADD. No cognitive/cardiometabolic benefit. If gut symptoms or frequent URTI present → OPTIONAL-ADD. MEDIUM confidence.
- 50+, mild cognitive decline / longevitySKIP-FOR-NOW
No longevity evidence; theoretical IGF-1/dairy-cancer concern is largely overblown for oral BC but precautionary frame still applies in active cancer surveillance. LOW confidence.
- Athletic male 18-35, high training loadSTRONG-CANDIDATE
during pre-comp peaking; OPTIONAL-ADD baseline. Davison cohort fits this profile. 20 g/day during 4-8 wk heavy blocks; cycle off during deloads.
- High athletic load, drug-tested (WADA / USADA / collegiate / amateur)OPTIONAL-ADD
WADA-permitted (not prohibited). Avoid "hyper-IGF-1"-marketed products. Stick to standard OTC + NSF Certified for Sport.
- Frequent URTI / repeated colds during fight campsSTRONG-CANDIDATE
Strongest evidence base; ~30-45% URTI day reduction (Jones 2016 meta-analysis).
- Heavy NSAID use (chronic ibuprofen/naproxen for training pain)STRONG-CANDIDATE
Marchbank/Davison NSAID-induced gut injury attenuation. Pair 20 g/day with NSAID block.
- Documented leaky gut / elevated zonulin / IBS / IBDSTRONG-CANDIDATE
Add to glutamine / glycine / probiotic / BPC-157 protocol. Halasa 2017 confirms direct zonulin reduction.
- Suspected (unmeasured) leaky gutPOSSIBLE
/ under-researched. Mechanism plausible but evidence base weak for unconfirmed symptom clusters; trial 20 g/day × 8 wk and assess.
- Pregnancy / breastfeedingLIKELY
SAFE (whole-food dairy, no documented harm) but no RCT data. Defer to OB if concerned.
- Cancer family history (hormone-sensitive cancers)CAUTION
Oral BC does not meaningfully elevate systemic IGF-1 (Davison 2021), so concern is overblown — but defer to oncologist in active surveillance.
- True milk allergy (IgE-mediated)HARD-BLOCK
Cross-reactive with casein, beta-lactoglobulin, alpha-lactalbumin. Risk of anaphylaxis.
- Lactose intolerance (mild-moderate)POSSIBLE
Most processed BC has <2% lactose, but not zero. Trial 5-10 g first; if GI distress persists, stop. Goat-derived (Mt. Capra) tolerated better by some.
- Strict vegan / dairy-avoidance ethicsHARD-BLOCK
by user preference. No vegan substitute matches the IgG/lactoferrin matrix.
- Combat-sport pre-competition (Dylan-specific)STRONG-CANDIDATE
during 6-8 wk pre-comp camp. Layer 20 g/day AM on V4/V5 baseline. Discontinue 1 wk pre-fight to avoid GI surprise.
▸ Subjective experience (deep)
Colostrum is subtle. Acute effects are essentially nil — no buzz, no euphoria, no obvious cognitive shift. The signal is what doesn't happen — slightly fewer minor sniffles during a hard training block, slightly less GI churn after gritty sessions, sometimes a vague sense of "gut is calmer" or "skin looks clearer." Onset to felt benefit (if any) is 2-6 weeks of continuous use. The phenomenology is closer to fish oil or probiotic than to creatine or modafinil — the win is observed in retrospect across a training block, not in a single dose.
In the first 1-2 weeks, GI tolerance issues are the main felt effect: bloating, gas, occasionally loose stool as the user adjusts to the dairy + casein + lactose load. This usually resolves within 5-10 days; if it doesn't, lactose intolerance or true dairy allergy is the likely cause and the user should stop.
At higher doses (40-60 g/day) some users report a slight sense of fullness / heaviness, mild GI distention, or reduced appetite. The protein/calorie load at 60 g is non-trivial (~225-240 kcal, ~20 g protein, ~5 g carb depending on source) — that's enough to interfere with appetite for the next meal, which matters during weight-cut phases or for athletes managing caloric targets tightly.
The "performance / strength / hypertrophy" subjective signal is weak — few users describe colostrum as moving the needle on training output the way creatine does. Some users in pre-camp blocks report subjectively faster recovery between heavy training sessions, but this is confounded with the immune/sleep effect rather than a direct anabolic mechanism.
Combat-sport specific: in fight-camp anecdotal reports, the most consistent subjective benefit is fewer "almost got sick" days — those moments where you wake up scratchy-throated, slightly headachey, and would normally call in sick, but the symptoms subside by mid-morning. Colostrum users often describe this pattern of "the cold that didn't quite happen" across a 6-8 week camp. This is consistent with the mechanism (luminal pathogen capture before invasion progresses) but is also exactly the kind of subjective signal most vulnerable to placebo / confirmation bias.
▸ Tolerance + cycling deep dive
- Tolerance buildup: none documented. The mechanism is largely passive (IgG cover, lactoferrin antimicrobial, growth-factor signaling) — not receptor-mediated. The body simply uses what's available; excess is digested.
- Recommended cycle: none required for daily 20g use. Block-cycling during heavy training / fight camps with off-periods during deloads is reasonable from a cost-efficacy standpoint — the immune-cover effect is most valuable when baseline immunity is suppressed by training stress.
- Reset protocol: N/A.
▸ Stacking deep dive
Synergistic with
- Lactoferrin (single ingredient). Already a major colostrum component; supplementing pure lactoferrin can reinforce gut antimicrobial + iron-binding effects. Largely redundant if already dosing 20-40g colostrum, but useful if isolating the lactoferrin signal.
- BPC-157. Both target gut barrier integrity but via different mechanisms — colostrum supplies passive IgG + growth factors at the lumen; BPC-157 is an active mucosal-repair signaling peptide. Complementary stack for athletes with documented exercise-induced gut leak or NSAID-induced gut injury.
- KPV. KPV suppresses NF-κB-driven inflammation; colostrum supplies passive IgG + growth factors. Anti-inflammatory + barrier-support pair. Both oral, both gut-targeted by kinetics.
- L-Glutamine. Glutamine fuels enterocytes; colostrum supplies sIgA-equivalent IgG + IGF-1 + TGF-β to lumen. Standard "gut healing" pair. Both daily-safe and cheap.
- Glycine. Adds collagen / connective-tissue support and gut-barrier substrate. Stack-safe and pairs cleanly with colostrum's growth-factor profile. Also doubles as a sleep-quality adjunct.
- Probiotics, zinc carnosine, deglycyrrhizinated licorice. Standard gut-healing protocol; colostrum slots in as the "passive immunity + growth factor" component.
Avoid stacking with
- Active milk allergy / severe dairy intolerance. Hard contraindication, not really "stacking" — just don't use.
- Hot liquids (acute). Coffee, tea, hot oatmeal — heat denatures IgG and lactoferrin. Mix into cool liquids only.
Neutral / safe co-administration
- Whey protein, casein protein, EAA, BCAA, creatine. All standard sport stacks. Stack-safe. Just count protein/calories.
- All V4 / V5 stack components (NAC, citicoline, magnesium glycinate + threonate, DHA, PS, curcumin, rhodiola, theanine, glycine, D3+K2, beta-alanine, vitamin C, taurine, modafinil, bromantane, ALCAR, apigenin, astaxanthin).
- Other peptides (BPC-157, TB-500, KPV, GHK-Cu, semaglutide, etc.) — no documented antagonism.
▸ Drug interactions deep dive
- CYP enzymes: Not a notable CYP inducer or inhibitor. No relevant interactions with modafinil, bupropion, or other CYP-metabolized drugs.
- Antibiotics (oral): Theoretically synergistic for gut decontamination via different mechanisms; no documented antagonism. Take antibiotics on a different schedule from colostrum if concerned.
- Iron supplements: Lactoferrin in colostrum is iron-binding; theoretical mild interference with non-heme iron absorption if dosed simultaneously. Separate by 2 hours if running a high-dose iron protocol.
- Immunosuppressants: No documented direct interaction; passive IgG load could theoretically modulate immune tone in transplant patients — defer to specialist.
- NSAIDs: Synergistic in the protective direction — colostrum attenuates NSAID-induced gut barrier injury (Davison/Marchbank). If running a chronic NSAID block, colostrum coverage is reasonable.
- Hyperimmune-state therapeutics (active autoimmune flare): Defer to specialist.
▸ Pharmacogenomics
Colostrum is a heterogeneous food-derived supplement; pharmacogenomic factors are limited and indirect:
- Lactase persistence (LCT / MCM6 region, rs4988235 etc.): Determines lactose tolerance. Colostrum has lower lactose than standard dairy but not zero; lactase non-persistent individuals may have GI symptoms.
- Milk allergy (HLA-DRB1 etc.): No actionable PGx; clinical history dominates.
- IGF-1 / IGFBP-3 polymorphisms: Theoretically modulate response to dietary IGF-1, but oral IGF-1 absorption is minimal — likely not actionable.
- 23andMe relevance for users in this archetype: Once results land (~June 2026), lactase-persistence (rs4988235) is the primary actionable variant — informs whether to trial colostrum at full dose vs start low + titrate. No other variants change supplementation decisions for this compound.
▸ Sourcing deep dive
What to look for on the label
The colostrum supplement market has wide quality variance. Critical spec items to demand:
- First-milking / "first 24 hours" or "first 6 hours" sourcing. IgG content drops 5-10× between hour 0 and hour 48 post-calving. The narrower the collection window, the higher the IgG. Premium products specify "first 24 hours" or even "first 6 hours."
- Standardized IgG content ≥20% by weight, ideally 30-40%. Some cheaper products contain only 10-15% IgG and are effectively dairy whey with marketing.
- Low-heat processing — spray-dried or freeze-dried, NOT UHT. Heat denatures IgG and lactoferrin. Products labeled "instant dissolve" or pasteurized via retort are degraded.
- Third-party Certificate of Analysis (COA). Should specify IgG %, lactoferrin %, microbial limits (E. coli, Salmonella, total aerobic count), and ideally heavy metals + pesticide residues.
- Calf welfare disclosure (optional but increasingly emphasized). Most ethical brands now disclose whether calves receive adequate colostrum first before any surplus is harvested. "Calf-first" or "post-calf" sourcing is a meaningful ethics differentiator if it matters to you — see the Controversies section.
Vendor table
| Path | Vendor | Cost | Reliability | Notes |
|---|---|---|---|---|
| OTC premium | Sovereign Laboratories Colostrum-LD (liposomal-protected) | $50-70 / 350g | High | Oft-cited premium brand; liposomal claim disputed in independent analysis but processing is reputable; first-milking spec'd; 25-30% IgG. |
| OTC premium | Symbiotics Colostrum Plus | $30-50 / 240g | High | Long-established brand; first-milking spec; standardized 30% IgG; transparent COA. |
| OTC premium | Surthrival Colostrum | $50-80 / 200-300g | High | Clean-sourced, transparent COA, popular in biohacker space; New Zealand grass-fed sourcing. |
| OTC premium | ARMRA Colostrum | $80-100 / 30 servings (~120 g) | Medium-High | High-priced; aggressive marketing; spec'd 200+ bioactive compounds but premium pricing relative to IgG content. |
| OTC mid-tier | Mt. Capra Colostrum (caprine — goat) | $40-60 / 240g | High | Goat-derived; lower cross-reactivity than cow for some sensitive users. Useful if you're sensitive to A1 beta-casein. |
| OTC bulk | Bulk Supplements Bovine Colostrum Powder | $25-40 / 250g | Medium-High | Cheapest per gram; 30% IgG spec; standard biohacker pick. |
| OTC bulk | NOW Foods Colostrum | $20-30 / bottle | Medium-High | Reputable; available iHerb/Amazon; matches V4 supplier flow. |
| OTC generic | Amazon generics | $15-25 / 200-300g | Medium-Low | Wide variability; demand third-party COA + IgG % on label. Many products in this tier are effectively dairy whey. |
Recommended for users in this archetype: Bulk Supplements (cheapest credible option; standard 30% IgG, matches V4 iHerb flow if substituted) or Sovereign Laboratories (premium / processing-quality argument; spec'd first-milking, low-heat). Cost is moderate (~$25-50/mo at 20 g/day depending on source).
Avoid: unbranded Amazon listings without COA, products that don't specify IgG %, products labeled "colostrum protein concentrate" without first-milking spec (likely dairy whey + minor colostrum fraction), and any product that recommends mixing into hot liquid.
▸ Biomarkers to track (deep)
- Baseline (before starting):
- URTI frequency log (last 6 months — count episodes, severity, days lost)
- Gut symptom log (bloating, irregularity, post-training GI distress)
- hsCRP (inflammation baseline)
- Zonulin if accessible (stool or serum; primarily research labs)
- Dairy tolerance check (subjective + lactose-breath-test if uncertain)
- During use:
- URTI frequency self-report (vs baseline)
- GI symptom log
- hsCRP at 8-12 weeks
- Skin check (acne tracking if dairy-sensitive)
- Post-cycle / off-block:
- Re-baseline URTI and gut symptoms in off-blocks vs on-blocks (informs block-cycle vs continuous decision)
- Specialty (research-grade): Salivary IgA, post-exercise lactulose/rhamnose (gut permeability), serum LPS / endotoxin, fecal calprotectin. Mostly research-only; not actionable for routine use.
▸ Controversies / open debates Live debate
Does oral IGF-1 actually raise serum IGF-1?
Vendor claim: Colostrum delivers anabolic IGF-1 systemically, supports muscle growth, "natural growth factor support."
Evidence: Oral IGF-1 is mostly degraded by gastric acid and pancreatic proteases. Mero 2002 showed transient serum IGF-1 rises at very high doses (60g+) but the effect was small and inconsistent. The 2021 Davison review (PMID 34073917) — the field's leading clinical investigator — concludes: "Early suggestions that supplementation with bovine colostrum products could increase systemic IGF-1 levels are not supported by the balance of available evidence examining a range of doses over both short- and long-term periods."
Practical update: Don't take colostrum expecting an anabolic IGF-1 effect. Local growth-factor signaling on enterocytes is real but doesn't translate to systemic muscle growth.
IGF-1 and cancer risk — overblown for oral colostrum
The "elevated IGF-1 → cancer promotion" pathway is biologically real (especially hormone-sensitive cancers — breast, prostate, colon) and underlies caution about high-protein diets, dairy, and rhGH/mecasermin. But the concern is dramatically attenuated for oral colostrum because it does not meaningfully elevate systemic IGF-1. Risk-benefit framing:
- Healthy adult, no cancer history: concern is overblown; oral BC does not chronically elevate IGF-1.
- Strong family history of hormone-sensitive cancer: precautionary frame applies but is not strongly supported by data; defer to clinician.
- Active cancer surveillance: defer to oncologist; lack of safety data in this cohort.
The concern would apply far more to injectable IGF-1 / mecasermin, not oral colostrum powder.
Hyperimmune vs OTC colostrum
Much of the strongest clinical evidence (infectious diarrhea, C. difficile, rotavirus) uses hyperimmune colostrum — from cows specifically immunized against target pathogens, producing antigen-specific IgG. OTC colostrum is not hyperimmune and has weaker, broader cover. The URTI and gut-permeability evidence cited in this entry is from standard OTC colostrum, so that use case is well-supported. The infectious-diarrhea / C. difficile evidence does NOT transfer cleanly to OTC.
IgG bioavailability — luminal vs systemic
Marketing sometimes implies colostrum IgG enters systemic circulation in adults. It largely does not. The neonatal gut is permeable to whole IgG for ~24 hours via FcRn; the adult gut digests most of it. The protective signal is luminal / mucosal — gut lumen, gut mucosa, salivary recycling to URT mucosa, Peyer's-patch / mesenteric lymph node circuit. "Supplementing IgG to fight systemic infection" is the wrong framing.
Heat-stable vs heat-denatured products
Improperly processed colostrum (high-heat retort, UHT) has substantially reduced IgG + lactoferrin activity. Practical action: demand first-milking spec, low-heat processing (spray-dried or freeze-dried), IgG % on the COA. Mix into cool/room-temp liquids only — hot coffee, tea, hot oatmeal all denature activity.
Acne / dairy-mediated breakouts
Users prone to dairy-mediated acne may flare on colostrum (mechanism: dairy IGF-1, milk hormones, casein-insulin signaling). Monitor in first 4-8 weeks. Goat-derived (Mt. Capra) may be better tolerated by users sensitive to A1 beta-casein.
Calf welfare / ethical sourcing
The neonatal calf requires colostrum within the first 24 hours for passive immunity transfer. The ethical question: does commercial harvest deprive the calf or collect surplus after adequate first feeding? Reputable practice is calf-first then surplus over the next 24-48 hours, but this is not universal. Premium brands (Sovereign, Surthrival, Mt. Capra) disclose calf-first protocols; cheap generics may not. For users where dairy ethics matters, prefer transparent vendors.
Standardization variability
Even within "first-milking" labeling, IgG content varies by source farm, season, breed, and processing. Independent COA testing has found products labeled "30% IgG" containing 10-25%. Best controls: buy from vendors with batch-specific COAs; accept 20% IgG minimum as realistic for non-premium; downweight subjective reports that don't specify brand.
Why URTI signal doesn't always replicate
A handful of trials (Shing 2007, PMID 21558575) show null URTI/immune effects. Pattern: when subjects are moderately trained rather than at peak training stress, baseline mucosal immunity is intact and BC's effect is washed out. The signal is reliably visible only when baseline immunity is depressed by training load + sleep debt + stress — which is why Dylan's pre-camp window is the relevant use case, and why "I felt nothing on colostrum during my off-season" is a non-falsifying anecdote.
▸ Verdict change log
2026-05-10 — Initial verdict: OPTIONAL-ADD / MEDIUM confidence at research-pass=medium. Replicated B-tier athlete URTI + gut-permeability evidence (Davison 2007, Marchbank 2011, March 2017) in the most relevant cohort for this user. Effect sizes modest but honest. Combat-sport context with heavy training load + gut/respiratory exposures fits the Davison cohort well. Not STRONG because (a) glutamine + BPC-157 already cover gut barrier; (b) cost and protein-load are non-trivial at 20-40g/day; (c) milk allergy / lactose intolerance can flip benefit to harm. Would upgrade to STRONG-CANDIDATE if recurrent URTI pattern develops during fight camps, zonulin or post-training endotoxin spillover documented, or heavy NSAID block.
2026-05-14 — Graduated to research-pass=thorough. Verdict unchanged: OPTIONAL-ADD / MEDIUM baseline, STRONG-CANDIDATE during pre-comp camps and heavy NSAID blocks. Key updates: (a) Corrected PMID citations (Halasa 2017 → 28397754, Crooks 2006 → 16676703, Davison/Diment 2010 → 20030905). (b) Added 2024 meta-analysis (PMID 38361147) confirming gut-barrier effect in at-risk cohorts with the caveat that healthy-baseline individuals may see slight permeability INCREASE — reinforces targeted-use framing. (c) Added 2024 high-dose RCT (PMID 39497827) — 25 g/day × 12 weeks elevates post-exercise salivary SIgA. (d) Added 2023 medical-student URTI RCT extending the URTI signal to non-athletic high-stress adults — relevant for business-owner + MMA dual-stress overlap. (e) Davison 2021 review (PMID 34073917) settles the IGF-1 systemic-elevation question in the null direction. (f) IGF-1 → cancer risk reframed as largely overblown for oral BC.
▸ Open questions / gaps Open
- Combat-sport URTI dynamics vs endurance-athlete cohort: most evidence comes from cyclists / runners / military training. Direct MMA / mixed-modal training data is thin.
- Optimal dose for gut-permeability outcome — 20g vs 40g vs 60g/day? Effect ceiling appears around 20g but inconsistent.
- Block-cycle (training-camp only) vs continuous dosing — equivalent immune cover? Plausible; not directly tested.
- Hyperimmune vs standard OTC for the URTI use case — most of the strongest immune evidence uses standard product, but hyperimmune for specific pathogens is a credible upgrade if available.
- Acne flare prevalence and predictors — anecdotal reports; not characterized in dose-response trials.
- Liposomal / "protected" colostrum claims — vendors claim better bioavailability; independent verification is light.
- Pharmacogenomic dose-response — lactase persistence is the obvious variable; no other clean PGx levers.
References
Davison G & Diment BC 2010 — Bovine colostrum supplementation attenuates the decrease of salivary lysozyme and enhances the recovery of neutrophil function after prolonged exercise (Br J Nutr) PMID 20030905
mechanism of immune cover during heavy exercise; salivary lysozyme + neutrophil function preserved
View StudyDavison 2007 — Bovine colostrum and immune function after prolonged exercise (PMID 17446836)
primary athlete URTI evidence baseline
View StudyBrinkworth GD & Buckley JD 2003 — Concentrated bovine colostrum protein supplementation reduces the incidence of self-reported symptoms of URTI in adult males (Eur J Nutr) PMID 12923655
URTI replication, 60 g/day × 12 weeks, n=148
View StudyCrooks CV et al. 2006 — The effect of bovine colostrum supplementation on salivary IgA in distance runners (Int J Sport Nutr Exerc Metab) PMID 16676703
sIgA mechanism; 79% sIgA rise vs placebo
View StudyMarchbank T et al. 2011 — The nutriceutical bovine colostrum truncates the increase in gut permeability caused by heavy exercise in athletes (Am J Physiol GI Liver Physiol) PMID 21148400
core gut-permeability evidence; 80% truncation of L/R ratio rise
View StudyHalasa M et al. 2017 — Oral Supplementation with Bovine Colostrum Decreases Intestinal Permeability and Stool Concentrations of Zonulin in Athletes (Nutrients) PMID 28397754
zonulin reduction during peak training; 500 mg/day × 20 days
View StudyBuckley JD et al. 2003 — Effect of an oral bovine colostrum supplement on running performance in trained men (J Sci Med Sport) PMID 12801212
athletic-performance cohort, 60 g/day × 8 weeks
View StudyMero A et al. 2002 — IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training (J Appl Physiol) PMID 12235031
serum IGF-1 response question (small/inconsistent rises at very high dose)
View StudyJones AW et al. 2014 — Effects of bovine colostrum supplementation on upper respiratory illness in active males (Brain Behav Immun) PMID 24200515
URTI replication, 20 g/day, active males
View StudyDavison G et al. 2018 — The effects of bovine colostrum supplementation on in vivo immunity following prolonged exercise: a randomised controlled trial (Eur J Nutr) PMID 29274034
in vivo immunity post-exercise
View StudyDavison G 2021 — The Use of Bovine Colostrum in Sport and Exercise (Nutrients) PMID 34073917
authoritative modern review; settles the IGF-1 systemic-elevation debate in the null direction
View StudyJones AW & Davison G 2016 — Bovine colostrum supplementation and upper respiratory symptoms during exercise training: a systematic review and meta-analysis of randomised controlled trials (BMC Sports Sci Med Rehabil) PMID 27462401
URS day reduction rate ratio 0.56 (95% CI 0.43-0.72)
View StudyNajmi M et al. 2024 — Bovine Colostrum in Increased Intestinal Permeability in Healthy Athletes and Patients: A Meta-Analysis of Randomized Clinical Trials (Dig Dis Sci) PMID 38361147
10-RCT meta-analysis; significant L/R + L/M reduction in at-risk cohorts; caveat for healthy baseline
View StudyMarch DS et al. 2017 — Intestinal damage, endotoxemia and gut permeability in athletes (review, PMID 28316573)
leaky-gut + endotoxemia signal in heavy-training athletes
View StudySienkiewicz M et al. 2024 — Exploring the impact of colostrum supplementation on athletes: a comprehensive analysis of clinical trials and diverse properties (Front Immunol)
recent narrative review
View StudyKotsis Y et al. 2023 — Moderate Dose Bovine Colostrum Supplementation in Prevention of URTI in Medical University Students (triple-blind RCT)
first trial in non-athletic high-stress adults; URTI frequency + severity reduced
View StudySkarpańska-Stejnborn A et al. 2024 — 12-week high-dose Colostrum Bovinum supplementation on immunological markers in endurance athletes (Front Immunol) PMID 39497827
25 g/day × 12 weeks, salivary SIgA rise sustained post-exercise
View StudyPlayford RJ & Weiser MJ 2021 — Bovine colostrum: its constituents and uses (Nutrients)
modern review of composition and clinical applications
View StudyWheeler TT et al. 2007 — Lactoferrin in bovine colostrum and milk and its functional role (J Dairy Sci) PMID 17517748
lactoferrin mechanism
View StudyBulk Supplements Bovine Colostrum Powder
vendor reference (cheapest per gram)
View SourceSovereign Laboratories Colostrum-LD
premium-tier vendor reference
View SourceLatest research
- rct12-week high-dose (25 g/day) Colostrum Bovinum supplementation on immunological markers in endurance athletes — randomized crossoverFirst trial of 25 g/day x 12 weeks in endurance-trained males. Significant post-exercise rise in salivary SIgA persisting to 1 h post-recovery. Hematocrit lower at recovery vs. placebo. No adverse safety signal at higher dose.
- reviewExploring the impact of colostrum supplementation on athletes — comprehensive review of clinical trials (Frontiers in Immunology)2024 narrative review of BC across athletic cohorts — strongest evidence is gut barrier + URTI; performance / body-comp effects remain inconsistent across replication attempts.
- meta-analysisBovine Colostrum in Increased Intestinal Permeability in Healthy Athletes and Patients — Meta-Analysis of Randomized Clinical TrialsPooled effect of 10 RCTs showed significant reduction in lactulose/rhamnose and lactulose/mannitol ratios after BC supplementation. Caveat — BC may slightly INCREASE permeability in healthy individuals without prior gut barrier impairment, reinforcing that the use case is at-risk / training-stressed populations, not asymptomatic baseline.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.